We just received data on a new analyst forecast for $BRO. Michael Zaremski from BMO Capital set a price target of 88.0 for BRO.
To track analyst ratings and price targets for $BRO, check out Quiver Quantitative's $BRO forecast page.
Should you buy $BRO?
Some analysts are better than others. To view the past performance of BMO Capital, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$BRO Price Targets
Multiple analysts have issued price targets for $BRO recently. We have seen 12 analysts offer price targets for $BRO in the last 6 months, with a median target of $91.5.
Here are some recent targets:
- Michael Zaremski from BMO Capital set a target price of $88.0 on 12/23/2025
- Jimmy Bhullar from JP Morgan set a target price of $91.0 on 12/18/2025
- Yaron Kinar from Mizuho set a target price of $89.0 on 12/16/2025
- Alex Scott from Barclays set a target price of $84.0 on 11/20/2025
- Bob Huang from Morgan Stanley set a target price of $85.0 on 11/17/2025
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $79.0 on 11/04/2025
- Joshua Shanker from B of A Securities set a target price of $97.0 on 11/03/2025
$BRO Insider Trading Activity
$BRO insiders have traded $BRO stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BRO stock by insiders over the last 6 months:
- PAUL J KRUMP purchased 2,678 shares for an estimated $249,884
- BRONISLAW EDMUND MASOJADA purchased 1,000 shares for an estimated $91,440
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BRO Revenue
$BRO had revenues of $1.6B in Q3 2025. This is an increase of 34.2% from the same period in the prior year.
You can track BRO financials on Quiver Quantitative's BRO stock page.
$BRO Congressional Stock Trading
Members of Congress have traded $BRO stock 18 times in the past 6 months. Of those trades, 13 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $BRO stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 5 times. They made 5 purchases worth up to $75,000 on 11/20, 10/31, 10/29, 09/18, 07/25 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 10/30, 08/04 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE BYRON DONALDS has traded it 5 times. They made 3 purchases worth up to $45,000 on 10/24, 10/09 and 2 sales worth up to $30,000 on 09/04.
- REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/26 and 1 sale worth up to $15,000 on 09/23.
- REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 08/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BRO Hedge Fund Activity
We have seen 497 institutional investors add shares of $BRO stock to their portfolio, and 500 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 7,827,992 shares (+81.1%) to their portfolio in Q3 2025, for an estimated $734,187,369
- CITADEL ADVISORS LLC removed 5,206,846 shares (-98.9%) from their portfolio in Q3 2025, for an estimated $488,350,086
- BALYASNY ASSET MANAGEMENT L.P. removed 4,440,154 shares (-99.6%) from their portfolio in Q3 2025, for an estimated $416,442,043
- FMR LLC added 3,513,727 shares (+41.6%) to their portfolio in Q3 2025, for an estimated $329,552,455
- VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. added 1,949,536 shares (+inf%) to their portfolio in Q3 2025, for an estimated $182,846,981
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC removed 1,921,699 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $213,058,768
- GHISALLO CAPITAL MANAGEMENT LLC removed 1,850,000 shares (-88.1%) from their portfolio in Q3 2025, for an estimated $173,511,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
